INmune Bio, Inc. Data at ASH Highlight Innovative Natural Killer Cell Therapeutic Platform Showing 100+ Day Persistence of Cancer Killing Memory Like NK Cells in Patients with AML/MDS Following Treatment with INKmune(TM)

December 8, 2022

Biotechnology

MAIA Biotechnology Announces $1.00 Million Private Placement

April 23, 2024
Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

April 23, 2024
Nutriband Inc. Announces $8.4M Private Placement

April 19, 2024
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million

April 18, 2024